Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study

被引:8
作者
El Miedany, Yasser [1 ]
El Gaafary, Maha [2 ]
Gadallah, Naglaa [3 ]
Mahran, Safaa [4 ]
Fathi, Nihal [4 ]
Abu Zaid, Mohamed Hassan [5 ]
Tabra, Samar Abdel Hamid [5 ]
Hassan, Waleed [6 ]
Elwakil, Walaa [7 ]
机构
[1] Canterbury Christ Church Univ, Inst Med Sci, Canterbury, England
[2] Ain Shams Univ, Community & Publ Hlth, Cairo, Egypt
[3] Ain Shams Univ, Rheumatol & Rehabil, Cairo, Egypt
[4] Assiut Univ, Rheumatol & Rehabil, Assiut, Egypt
[5] Tanta Univ, Rheumatol & Rehabil, Tanta, Egypt
[6] Benha Univ, Rheumatol & Rehabil, Banha, Egypt
[7] Alexandria Univ, Rheumatol Physcial Med & Rehabil, Alexandria, Egypt
关键词
Osteoporosis; Treatment gap; Imminent fracture; Risk; Falls; Sarcopenia; Egyptian Academy of Bone Health; MANAGEMENT; WOMEN;
D O I
10.1007/s11657-023-01252-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite the wide availability of a wide variety of approved osteoporosis medications and DXA scan centers in Egypt, only a minority of patients at high risk of sustaining a fragility fracture receive treatment, even after their first fracture. Such big "treatment gap" leaves the most high-risk individuals unprotected against fragility fractures. This study provides a benchmark to monitor national trends in osteoporosis management and service uptake.PurposeTo assess the treatment gap among men and postmenopausal women presenting with a fragility fracture, and to analyze the characteristics and fracture risks of the patients presenting with an index fragility fracture.MethodsThis was a multi-center, cross-sectional, observational study. Both men and postmenopausal women, admitted with an osteoporotic fracture (whether major osteoporosis or hip fracture), were consecutively recruited for this work. The fracture risk was assessed based on their FRAX calculation prior to the index fracture. All the patients were assessed for their falls and sarcopenia risks. Blood tests for bone profile as well as DXA scan were offered to all the patients.ResultsTwo hundred and thirty-six patients presenting with fragility fractures were included in this work. 70.8% were women and 29.2% were men. Mean age was 70.1 (SD = 9.2) years. Ten-year probability of fracture (without BMD) was high in 65.9% of the postmenopausal women and 40.3% of the men. 82.1% of the postmenopausal women and 100% in men identified to be eligible for osteoporosis therapy did not receive any form of osteoporosis therapy. FRAX score correlated significantly with bone mineral density assessment at both hip and spine. Falls, sarcopenia, and functional disability showed significant relation to the fracture risk.ConclusionsThere is a large treatment gap in Egyptian older adults. The recent guidelines for osteoporosis management in Egypt endorsed fracture centric approach to identify people at risk. The gap appears to be related to a low rate of osteoporosis diagnosis and lack of patient education.
引用
收藏
页数:9
相关论文
共 20 条
  • [11] Imminent risk of fracture after fracture
    Johansson, H.
    Siggeirsdottir, K.
    Harvey, N. C.
    Oden, A.
    Gudnason, V.
    McCloskey, E.
    Sigurdsson, G.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (03) : 775 - 780
  • [12] FRAX™ and the assessment of fracture probability in men and women from the UK
    Kanis, J. A.
    Johnell, O.
    Oden, A.
    Johansson, H.
    McCloskey, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 385 - 397
  • [13] Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting
    Kanis, J. A.
    Cooper, C.
    Rizzoli, R.
    Abrahamsen, B.
    Al-Daghri, N. M.
    Brandi, M. L.
    Cannata-Andia, J.
    Cortet, B.
    Dimai, H. P.
    Ferrari, S.
    Hadji, P.
    Harvey, N. C.
    Kraenzlin, M.
    Kurth, A.
    McCloskey, E.
    Minisola, S.
    Thomas, T.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (07) : 2023 - 2034
  • [14] The Osteoporosis Treatment Gap
    Kanis, John A.
    Svedbom, Axel
    Harvey, Nicholas
    McCloskey, Eugene V.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (09) : 1926 - 1928
  • [15] Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
  • [16] SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
    Malmstrom, Theodore K.
    Miller, Douglas K.
    Simonsick, Eleanor M.
    Ferrucci, Luigi
    Morley, John E.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (01) : 28 - 36
  • [17] The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
    McCloskey, E.
    Rathi, J.
    Heijmans, S.
    Blagden, M.
    Cortet, B.
    Czerwinski, E.
    Hadji, P.
    Payer, J.
    Palmer, K.
    Stad, R.
    O'Kelly, J.
    Papapoulos, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (02) : 251 - 259
  • [18] Imminent fracture risk
    Roux, C.
    Briot, K.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (06) : 1765 - 1769
  • [19] Importance of Recent Fracture as Predictor of Imminent Fracture Risk
    Schnell, Amanda D.
    Curtis, Jeffrey R.
    Saag, Kenneth G.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2018, 16 (06) : 738 - 745
  • [20] Osteoporosis: burden, health care provision and opportunities in the EUA report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)
    O. Ström
    F. Borgström
    John A. Kanis
    Juliet Compston
    Cyrus Cooper
    Eugene V. McCloskey
    Bengt Jönsson
    [J]. Archives of Osteoporosis, 2011, 6 (1-2) : 59 - 155